Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_aa9e891fe2cef9eaca80a55f7c8415b8 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B59-002 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B59-004 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K51-0402 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K51-0482 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K51-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07B59-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
filingDate |
2021-01-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2021-09-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_41015a851eb85124af121b417e7f03b1 |
publicationDate |
2021-09-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-11129912-B1 |
titleOfInvention |
Radiopharmaceutical and methods |
abstract |
The radiopharmaceutical 177 Lu-PSMA I&T is provided, including in high purities with extended shelf life. Further provided are methods of synthesis of 177 Lu-PSMA I&T and pharmaceutical compositions and methods of treatment that comprise 177 Lu-PSMA I&T. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11491246-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2023097329-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022013610-A3 |
priorityDate |
2020-07-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |